Interleukin (IL)-18 is a cytokine previously demonstrated to participate in neuroinflammatory processes. Since the components of the IL-18 receptor complex are expressed in neurons throughout the brain, IL-18 is also believed to directly influence neuronal function. Here we tested this hypothesis on mouse hippocampal neurons by measuring the effects of IL-18 on three pathways previously shown to be regulated by this cytokine in non-neuronal cells: the MAPK pathways, p38 and ERK1/2 MAPKs, STAT3 and NF-jB. Experiments were carried out in vitro using the immortalized hippocampal neuronal line HT-22 or in vivo following i.c.v. injection with recombinant mouse IL-18. We showed that IL-18 did not activate NF-jB in HT-22 cells whereas it induced a rapid (within 15 min) activation of the MAPK pathways. Moreover, we demonstrated that IL-18 treatment enhanced P-STAT3 (Tyr705)/STAT3 ratio in the nucleus of HT-22 cells after 30-60 min of exposure. A similar increase in P-STAT3 (Tyr705)/STAT3 ratio was observed in the whole hippocampus one hour after i.c.v. injection. These data demonstrate that IL-18 can act directly on neuronal cells affecting the STAT3 pathway; therefore, possibly regulating the expression of specific genes within the hippocampus. This effect may help to explain some of the IL-18-induced effects on synaptic plasticity and functionality within the hippocampal system.
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Introduction
Interleukin (IL)-18 is a pleiotropic cytokine belonging to the IL-1 family that has several established roles both in innate and adaptive immune responses (Nakanishi et al., 2001) . IL-18 mediates a variety of effects in virtually every organ system of the body by interacting with its heterodimer receptor (IL-18R) that consists of a subunit a (type I IL-18Ra, required for binding), and a subunit b (full-length IL-18Rb, responsible for signal transduction) (Sergi and Penttila, 2004) . Besides the periphery, and the cells of the immune system, the IL-18/IL-18R system is expressed and active also in the brain in both glia cell populations (including microglia, astrocyte and ependymal cells) and neurons. Interestingly, the central action of IL-18 appears to be tightly regulated. Indeed, aside the first characterized negative regulator of IL-18-mediated actions, the IL-18 binding protein (BP) (Novick et al., 1999) , a short transcript IL-18Ra that lacks the TIR domain (type II IL-18Ra) and a soluble form IL-18Rb (small IL-18Rb) exists (Alboni et al., 2009; Alboni et al., 2011a,b) .
In the last few years it has been demonstrated that the IL-18/IL-18R system may have broad-ranging actions in the healthy as well as the pathological brain (Alboni et al., 2010) . On the ''physiological'' side, it has been reported that this cytokine affects neuronal differentiation, survival and synaptic plasticity. Liu and colleagues reported that IL-18 may reduce survival and attenuate neuronal cell fate in cultured embryonic rat-derived neuronal progenitor cells (Liu et al., 2005) . However, very recently it has been demonstrated that hippocampal levels of IL-18 correlate positively with hippocampal neurogenesis following physical exercise in aging rats (Speisman et al., 2012) . Moreover, the role of IL-18 in synaptic plasticity in the dentate gyrus (DG) of the hippocampus system has been demonstrated (Curran and O'Connor, 2001; Cumiskey et al., 2007; del Rey et al., 2013) . Beside its role in long-term potentiation (LTP), this pro-inflammatory mediator is involved in certain types of learning. A role for IL-18 in favoring spatial memory was
